Comparative genomic hybridization (CGH) is a technique that has greatly facilitated detection of gains and losses in DNA copy number, and has been of particular utility in elucidating the pattern of ...
MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen, Inc. has launched NimbleGen Comparative Genomic Hybridization (CGH) microarrays in a 12x135K format for analysis of DNA copy number variation.
Mendelian disorders are most commonly caused by mutations identifiable by DNA sequencing. Exonic deletions and duplications can go undetected by sequencing, and their frequency in most Mendelian ...
Expert Rev Mol Diagn. 2012;12(3):253-264. Starczynowski et al. (2008) Low-risk MDS (44; IPSS ≤1.0) Discovery: array CGH with whole-genome BAC tiling array Validation: FISH of a selected locus Paired ...
Background: To apply high throughput technologies (CGH array, Hot Spot Mutations arrays) in daily practice in order to drive patients to tailored targeted therapies. Methods: High resolution ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that scientists using the company’s comparative genomic hybridization (CGH) technology have shown that cancer ...
infoQuant Ltd brings microarray technology closer to clinical use with its latest release of copy number analysis and interpretation software "oneClickCGH" and "CGH Fusion" for microarray-based ...
Microarray based comparative genomic hybridisation (array CGH) is a new technology with uses developing in various diagnostic areas within the NHS. One important context is the investigation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback